Functional Identification of the Dextransucrase Gene of Leuconostoc mesenteroides DRP105

Enhanced dextran production by Weissella confusa in co-culture with Candida shehatae and its quorum sensing regulation mechanism

Lactic acid bacteria (LAB) are well-known for its expertise in synthesizing exopolysaccharides (EPS), which are linked to significant health benefits, such as its prebiotic effects and ability to modulate the immune system. However, the synthesis of EPS is hindered by low yields. The objective of this study was to investigate the impact of co-cultivation on EPS output by Weissella confusa XG-3 when paired with Candida shehatae. The structure and characteristics of the purified EPS were analyzed. Gel permeation chromatography (GPC) revealed a molecular weight of 3.45 × 106 Da. High-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy and fourier transform infrared (FT-IR) spectroscopy showed that the EPS was a linear homopolysaccharide, mainly composed of glucose units, with a proposed structure of dextran featuring α-(1, 6) glycosidic linkages and occasional α-(1,3) branching. Fermentation processes were conducted in both mono-culture and co-culture settings, with tracking of pivotal gene expression. The result showed that the expression of luxS, ackA and wzb was significantly up-regulated in the co-culture system, which was positively correlated with dextransucrase activity and dextran production. C. shehatae promoted the growth of W. confusa XG-3 by consuming organic acids in the culture system through direct contact, initiating quorum sensing (QS), inducing dsr expression, increasing dextransucrase activity, and ultimately promoting dextran synthesis.

Advancements in gene editing technologies for probiotic-enabled disease therapy

Probiotics typically refer to microorganisms that have been identified for their health benefits, and they are added to foods or supplements to promote the health of the host. A growing number of probiotic strains have been identified lately and developed into valuable regulatory pharmaceuticals for nutritional and medical applications. Gene editing technologies play a crucial role in addressing the need for safe and therapeutic probiotics in disease treatment. These technologies offer valuable assistance in comprehending the underlying mechanisms of probiotic bioactivity and in the development of advanced probiotics. This review aims to offer a comprehensive overview of gene editing technologies applied in the engineering of both traditional and next-generation probiotics. It further explores the potential for on-demand production of customized products derived from enhanced probiotics, with a particular emphasis on the future of gene editing in the development of live biotherapeutics.

In Silico Analysis of the Dextransucrase Obtained From Leuconostoc mesenteroides Strain IBUN 91.2.98

The DSR-IBUN dextransucrase produced by Leuconostoc mesenteroides strain IBUN 91.2.98 has a short production time (4.5 hours), an enzymatic activity of 24.8 U/mL, and a specific activity of purified enzyme 2 times higher (331.6 U/mg) than that reported for similar enzymes. The aim of this study was to generate a structural model that, from an in silico approach, allows a better understanding, from the structural point of view, of the activity obtained by the enzyme of interest, which is key to continue with its study and industry application. For this, we translated the nucleotide sequence of the dsr_IBUN gene. With the primary structure of DSR-IBUN, the in silico prediction of physicochemical parameters, the possible subcellular localization, the presence of signal peptide, and the location of domains and functional and structural motifs of the protein were established. Subsequently, its secondary and tertiary structure were predicted and a homology model of the dextransucrase under study was constructed using Swiss-Model, performing careful template selection. The values obtained for the model, Global Model Quality Estimation (0.63), Quality Mean (-1.49), and root-mean-square deviation (0.09), allow us to affirm that the model for the enzyme dextransucrase DSR-IBUN is of adequate quality and can be used as a source of information for this protein.